Chytridiomycosis

Chytridiomycosis (kaɪˌtrɪdiəmaɪˈkoʊsɪs ) is an infectious disease in amphibians, caused by the chytrid fungi Batrachochytrium dendrobatidis and Batrachochytrium salamandrivorans. Chytridiomycosis has been linked to dramatic population declines or extinctions of amphibian species in western North America, Central America, South America, eastern Australia, east Africa (Tanzania), and Dominica and Montserrat in the Caribbean. Much of the New World is also at risk of the disease arriving within the coming years. The fungus is capable of causing sporadic deaths in some amphibian populations and 100% mortality in others. No effective measure is known for control of the disease in wild populations. Various clinical signs are seen by individuals affected by the disease. A number of options are possible for controlling this disease-causing fungus, though none has proved to be feasible on a large scale. The disease has been proposed as a contributing factor to a global decline in amphibian populations that apparently has affected about 30% of the amphibian species of the world. Some research found evidence insufficient for linking chytrid fungi and chytridiomycosis to global amphibian declines, but more recent research establishes a connection and attributes the spread of the disease to its transmission through international trade routes into native ecosystems. Whether chytridiomycosis is a new, emergent pathogen or an extant pathogen with recently increased virulence is unclear. The disease in its epizootic form was first discovered in 1993 in dead and dying frogs in Queensland, Australia. It had been present in the country since at least 1978 and is widespread across Australia. It is also found in Africa, the Americas, Europe, New Zealand, and Oceania. In Australia, Panama, and New Zealand, the fungus seemed to have suddenly 'appeared' and expanded its range at the same time frog numbers declined. In the Americas, it originated in Venezuela in 1987, where it swept up the continent into Central America.